Segui
Daniel J Müller (Mueller)
Daniel J Müller (Mueller)
Professor, University of Toronto / Centre for Addiction and Mental Health
Email verificata su camh.ca - Home page
Titolo
Citata da
Citata da
Anno
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 3. Pharmacological …
SH Kennedy, RW Lam, RS McIntyre, SV Tourjman, V Bhat, P Blier, ...
The Canadian Journal of Psychiatry 61 (9), 540-560, 2016
11492016
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake …
JK Hicks, JR Bishop, K Sangkuhl, DJ Müller, Y Ji, SG Leckband, ...
Clinical Pharmacology & Therapeutics 98 (2), 127-134, 2015
9712015
Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC®) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update
JK Hicks, K Sangkuhl, JJ Swen, VL Ellingrod, DJ Müller, K Shimoda, ...
Clinical pharmacology and therapeutics 102 (1), 37, 2017
6372017
Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants
JK Hicks, JJ Swen, CF Thorn, K Sangkuhl, ED Kharasch, VL Ellingrod, ...
Clinical Pharmacology & Therapeutics 93 (5), 402-408, 2013
5192013
Incorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development process
KE Caudle, TE Klein, JM Hoffman, DJ Müller, M Whirl-Carrillo, L Gong, ...
Current drug metabolism 15 (2), 209, 2014
4462014
Molecular mechanisms of schizophrenia
UE Lang, I Puls, DJ Müller, N Strutz-Seebohm, J Gallinat
Cellular Physiology and Biochemistry 20 (6), 687-702, 2007
3972007
Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications
TAP Lett, TJM Wallace, NI Chowdhury, AK Tiwari, JL Kennedy, DJ Müller
Molecular Psychiatry 17 (3), 242-266, 2011
2962011
Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy
KR Crews, AA Monte, R Huddart, KE Caudle, ED Kharasch, A Gaedigk, ...
Clinical Pharmacology & Therapeutics 110 (4), 888-896, 2021
2952021
Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA‐B Genotype and Carbamazepine Dosing
SG Leckband, JR Kelsoe, HM Dunnenberger, AL George Jr, E Tran, ...
Clinical Pharmacology & Therapeutics 94 (3), 324-328, 2013
2632013
Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update
EJ Phillips, C Sukasem, M Whirl‐Carrillo, DJ Müller, HM Dunnenberger, ...
Clinical Pharmacology & Therapeutics 103 (4), 574-581, 2018
2622018
Association between a functional polymorphism in the monoamine oxidase A gene promoter and major depressive disorder
TG Schulze, DJ Müller, H Krauss, H Scherk, S Ohlraun, YV Syagailo, ...
American Journal of Medical Genetics 96 (6), 801-803, 2000
2392000
Association between common variants near the melanocortin 4 receptor gene and severe antipsychotic drug–induced weight gain
AK Malhotra, CU Correll, NI Chowdhury, DJ Müller, PK Gregersen, ...
Archives of general psychiatry 69 (9), 904-912, 2012
2112012
Comprehensive allelotype and genetic analysis of 466 human nervous system tumors
A von Deimling, R Fimmers, MC Schmidt, B Bender, F Fassbender, ...
Journal of Neuropathology & Experimental Neurology 59 (6), 544-558, 2000
2092000
Antipsychotics, metabolic adverse effects, and cognitive function in schizophrenia
NE MacKenzie, C Kowalchuk, SM Agarwal, KA Costa-Dookhan, ...
Frontiers in psychiatry 9, 622, 2018
1932018
Pharmacogenetic allele nomenclature: International workgroup recommendations for test result reporting
LV Kalman, JAG Agúndez, ML Appell, JL Black, GC Bell, S Boukouvala, ...
Clinical Pharmacology & Therapeutics 99 (2), 172-185, 2016
1932016
Clinical Pharmacogenetics Implementation Consortium Guideline for Cytochrome P450 (CYP)2D6 Genotype and Atomoxetine Therapy
JT Brown, JR Bishop, K Sangkuhl, EL Nurmi, DJ Mueller, JC Dinh, ...
Clinical Pharmacology & Therapeutics 106 (1), 94-102, 2019
1872019
Genetics of antipsychotic treatment emergent weight gain in schizophrenia
DJ Müller, JL Kennedy
Pharmacogenomics 7 (6), 863-887, 2006
1852006
An international adult guideline for making clozapine titration safer by using six ancestry-based personalized dosing titrations, CRP, and clozapine levels
J De Leon, G Schoretsanitis, RL Smith, E Molden, A Solismaa, N Seppälä, ...
Pharmacopsychiatry 55 (02), 73-86, 2022
1822022
MicroRNAs 146a/b-5 and 425-3p and 24-3p are markers of antidepressant response and regulate MAPK/Wnt-system genes
JP Lopez, LM Fiori, C Cruceanu, R Lin, B Labonte, HM Cates, EA Heller, ...
Nature communications 8 (1), 15497, 2017
1802017
Evidence of association between smoking and alpha7 nicotinic receptor subunit gene in schizophrenia patients.
V De Luca, AHC Wong, DJ Muller, GW Wong, RF Tyndale, JL Kennedy
Neuropsychopharmacology 29 (8), 1522-1526, 2004
1772004
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20